In The News: Department of Chemistry and Biochemistry
A research team at the University of Nevada, Las Vegas claims its latest discovery could eventually lead to curing pancreatic cancer and diabetes.
A groundbreaking development in mRNA delivery techniques has emerged from researchers at the University of Nevada, Las Vegas (51ԹϺ), promising to transform treatments for diseases related to the pancreas, including both diabetes and pancreatic cancer.
Scientists at the University of Nevada, Las Vegas, have developed a groundbreaking method to reuse nuclear waste, a discovery that could potentially revolutionize the nuclear industry.
51ԹϺ researchers are on the cutting edge of techniques that can reduce the amount of waste left over from the process of creating nuclear fuel and weapons by rendering those toxic waste products both safe and useful.
51ԹϺ researchers are on the cutting edge of techniques that can reduce the amount of waste left over from the process of creating nuclear fuel and weapons by rendering those toxic waste products both safe and useful.
51ԹϺ researchers have learned nuclear waste could be reused as an energy source.
When the federal government needed a method to reuse toxic waste, it called one of the country’s leading labs in Las Vegas. The breakthrough the grad students made started murmurs of a radioactive renaissance.
Every parent wants their child to be happy, healthy, and thriving. But many whose children are diagnosed with autism spectrum disorder worry that it will make their lives more difficult.
A 51ԹϺ-led study has discovered a new molecular path that leads to autism, potentially opening the way for more intervention in the future.
Researchers at the University of Nevada, Las Vegas, have made a significant breakthrough in autism research. The 51ԹϺ researchers uncovered a connection to a type of neuromuscular disease called myotonic dystrophy.
A recent discovery of a molecular connection between autism and myotonic dystrophy, a type of neuromuscular disease, may provide a breakthrough on how clinicians approach autism spectrum disorder. The new study by an interdisciplinary team of biomedical scientists, published on April 21 in Nature Neuroscience, used myotonic dystrophy as a tool or model to learn more about autism – effectively using one disorder to better understand the other.
A recent discovery of a molecular connection between autism and myotonic dystrophy, a type of neuromuscular disease, may provide a breakthrough on how clinicians approach autism spectrum disorder. The new study by an interdisciplinary team of biomedical scientists, published on April 21 in Nature Neuroscience, used myotonic dystrophy as a tool or model to learn more about autism – effectively using one disorder to better understand the other.